ONCY

Oncolytics Biotech
ONCY

50 hedge funds and large institutions have $750K invested in Oncolytics Biotech in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

38% less capital invested

Capital invested by funds: $1.21M → $750K (-$456K)

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$27.8K
2
+$22K
3
+$16.7K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$11K
5
TSS
Two Sigma Securities
New York
+$8.34K

Top Sellers

1
-$90K
2
-$32.9K
3
-$7.13K
4
Morgan Stanley
Morgan Stanley
New York
-$3.02K
5
BHWM
Beaird Harris Wealth Management
Texas
-$754
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$7.97K
27
$7.92K
28
$7.91K
29
$7.33K
30
$7.11K
31
$6.17K
32
$4.93K
33
$4.24K
34
$3.11K
35
$3K
36
$2.75K
37
$2.57K
38
$2.42K
39
$1.82K
40
$1.65K
41
$1.43K
42
$1K
43
$550
44
$290
45
$209
46
$116
47
$107
48
$80
49
$28
50
$23
1
2
3